Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Clinical Psychiatry

• Publication date

  2007-03-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.4088/JCP.V68N0306PMID 17388708
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacotherapy for Obesity

  2012cited by this paper
• The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication.

  2007cited by this paper
• Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial

  2006cited by this paper
• Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.

  2006cited by this paper
• Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.

  2006cited by this paper
• Augmentation with open-label atomoxetine for partial or nonresponse to antidepressants.

  2005cited by this paper
• Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison.

  2005cited by this paper
• Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder.

  2005cited by this paper
• A comparison of quality of life in obese individuals with and without binge eating disorder.

  2005cited by this paper
• Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: a randomized, double-blind, placebo-controlled trial.

  2005cited by this paper
• Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms.

  2005cited by this paper
• Effect of orlistat in obese patients with binge eating disorder.

  2005cited by this paper
• Use of sibutramine an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: A placebo-controlled study

  2005cited by this paper
• Continuous care in the treatment of obesity: an observational multicentre study

  2005cited by this paper
• Subtypes of binge eating disorder based on psychiatric history.

  2005cited by this paper
• A randomized controlled comparison of guided self-help cognitive behavioral therapy and behavioral weight loss for binge eating disorder.

  2005cited by this paper
• Travel distance and attrition in outpatient eating disorders treatment.

  2005cited by this paper
• Modulation of eating by central catecholamine systems.

  2005cited by this paper
• Brown adipose tissue: function and physiological significance.

  2004cited by this paper
• Pharmacological approaches in the treatment of binge eating disorder.

  2004cited by this paper
• Topiramate in the long-term treatment of binge-eating disorder associated with obesity.

  2004cited by this paper
• What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews

  2004cited by this paper
• Atomoxetine, a Novel Treatment for Attention‐Deficit—Hyperactivity Disorder

  2004cited by this paper
• Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

  2003cited by this paper
• Medical morbidity in binge eating disorder.

  2003cited by this paper
• Pharmacologic treatment of binge eating disorder.

  2003cited by this paper
• A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.

  2003cited by this paper
• Psychological and dietary treatments of binge eating disorder: conceptual implications.

  2003cited by this paper
• Assessing and interpreting treatment effects in longitudinal clinical trials with missing data.

  2003cited by this paper
• Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.

  2003cited by this paper
• Binge eating disorder and obesity in 2003: could treating an eating disorder have a positive effect on the obesity epidemic?

  2003cited by this paper
• Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.

  2003cited by this paper
• A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder.

  2002cited by this paper
• A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment.

  2002cited by this paper
• Health problems, impairment and illnesses associated with bulimia nervosa and binge eating disorder among primary care and obstetric gynaecology patients

  2001cited by this paper
• Different methods for assessing the features of eating disorders in patients with binge eating disorder: a replication.

  2001cited by this paper
• Placebo-controlled trial of sertraline in the treatment of binge eating disorder.

  2000cited by this paper
• Outcome predictors for the cognitive behavior treatment of bulimia nervosa: data from a multisite study.

  2000cited by this paper
• Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial.

  1998cited by this paper
• The selective norepinephrine reuptake inhibitor, LY368975, reduces food consumption in animal models of feeding.

  1998cited by this paper
• Association of binge eating disorder and psychiatric comorbidity in obese subjects.

  1993cited by this paper
• Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset.

  1993cited by this paper
• The Yale-Brown Obsessive Compulsive Scale. II. Validity.

  1989cited by this paper

• Pharmacological management of binge eating disorder

  2025cites this paper
• Pharmacotherapies for Binge Eating Disorder: Systematic Review and Network Meta‐Analysis

  2025cites this paper
• Consider co-occurring conditions when selecting pharmacological treatment options for binge eating disorder

  2025cites this paper
• Psychedelics and the Serotonin Hypothesis of Eating Disorders

  2025cites this paper
• SADR: Self-Supervised Graph Learning With Adaptive Denoising for Drug Repositioning

  2024cites this paper
• Bulimia Nervosa and Binge-Eating Disorder Across the Lifespan.

  2024cites this paper
• Pharmacological Treatment of Binge Eating Disorder and Frequent Comorbid Diseases

  2024cites this paper
• The Potential Benefit of Atomoxetine for Treating Aggression and Violence in an Adult Patient with Down Syndrome and Intellectual Disability

  2024cites this paper
• Systematic Review of Binge Eating Rodent Models for Developing Novel or Repurposing Existing Pharmacotherapies

  2023cites this paper
• Pharmacological strategies for appetite modulation in eating disorders: a narrative review

  2023cites this paper
• Adrenoceptors: A Focus on Psychiatric Disorders and Their Treatments.

  2023cites this paper
• Adaptive learning from outcome contingencies in eating-disorder risk groups

  2023cites this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders

  2023cites this paper
• Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence

  2023cites this paper
• An exploratory machine learning approach to identify placebo responders in pharmacological binge eating disorder trials

  2022cites this paper
• Psychopharmacologic Management of Eating Disorders

  2022cites this paper
• Novel Approaches to Tackling Emotional Loss of Control of Eating Across the Weight Spectrum.

  2022cites this paper
• What pharmacological interventions are effective in binge-eating disorder? Insights from a critical evaluation of the evidence from clinical trials

  2022cites this paper
• Management of eating disorders for people with higher weight: clinical practice guideline

  2022cites this paper
• The Role of the Noradrenergic System in Eating Disorders: A Systematic Review

  2021influential citation
• HeTDR: Drug repositioning based on heterogeneous networks and text mining

  2021cites this paper
• Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology

  2021cites this paper
• Atomoxetine Reduced Binge/Purge Symptoms in a Case of Anorexia Nervosa Binge/Purge Type.

  2021influential citation
• BINGE EATING DISORDERS; UPDATED AND EMERGING APPROACHES

  2021cites this paper
• Eating Disorders (Anorexia Nervosa and Bulimia Nervosa, Binge Eating Disorder)

  2021cites this paper
• Atomoxetine in-focus!

  2020cites this paper
• Smartphone-Based Interventions for Physical Activity Promotion: Scoping Review of the Evidence Over the Last 10 Years

  2020cites this paper
• Medication for Binge Eating

  2020cites this paper
• Binge Eating Disorder in Adolescents and Emerging Adults

  2020cites this paper
• Adolescent Nutrition: Assuring the Needs of Emerging Adults

  2020cites this paper
• Meta-analysis on the long-term effectiveness of psychological and medical treatments for binge-eating disorder.

  2020cites this paper
• The Treatment of Adult ADHD: Complexity at Hand

  2020cites this paper
• Adult ADHD in Feeding and Eating Disorders

  2020cites this paper
• Effects of 5-HT2C receptor modulation and the NA reuptake inhibitor atomoxetine in tests of compulsive and impulsive behaviour.

  2020cites this paper
• Medikamente zur Behandlung von Essstörungen und Adipositas

  2020cites this paper
• Binge Eating: A Transdiagnostic Psychopathology

  2020cites this paper
• 2-1-2018 Relationships Between Clinical Scales and Binge Eating Days in Adults with Moderate to Severe Binge Eating Disorder in Two Phase III Studies

  2019cites this paper
• Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice

  2019cites this paper
• Pharmacologic Treatment of Eating Disorders.

  2019cites this paper
• Investigational drugs for the treatment of binge eating disorder (BED): an update

  2019cites this paper
• Psychopharmacological Options in the Multidisciplinary and Multidimensional Treatment of Eating Disorders

  2019cites this paper
• Reduced Sensory-Evoked Locus Coeruleus-Norepinephrine Neural Activity in Female Rats With a History of Dietary-Induced Binge Eating

  2019cites this paper
• A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder

  2019cites this paper
• Study protocol and rationale for a randomized double-blinded crossover trial of phentermine-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa.

  2018cites this paper
• Advances in BAT physiology for understanding and translating into Pharmacotherapies for obesity and comorbidities

  2018cites this paper
• Weight Loss During Atomoxetine Add-on to Clozapine-Responsive Schizophrenia.

  2018cites this paper
• Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studies

  2018cites this paper
• Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa

  2018cites this paper
• omorbidity of bipolar disorder and eating disorders

  2018cites this paper
• Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review.

  2018cites this paper
• Human brown adipose tissue — function and therapeutic potential in metabolic disease

  2017cites this paper
• Pharmacologic Treatments for Binge-Eating Disorder.

  2017cites this paper
• Binge‐eating disorder: Clinical and therapeutic advances

  2017cites this paper
• Gambling disorder: an integrative review of animal and human studies

  2017cites this paper
• Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial

  2017cites this paper
• Molecular bases of anorexia nervosa, bulimia nervosa and binge eating disorder: shedding light on the darkness

  2017cites this paper
• Efficacy of N-Acetylcysteine Augmentation on Obsessive Compulsive Disorder: A Multicenter Randomized Double Blind Placebo Controlled Clinical Trial

  2017cites this paper
• Identification phénoménologique des substrats neurobiologiques de la relation impulsivité / compulsivité : approche transnosographique

  2017cites this paper
• Cocaine and desipramine elicit distinct striatal noradrenergic and behavioral responses in selectively bred obesity‐resistant and obesity‐prone rats

  2017cites this paper
• Appetite and weight loss in children on atomoxetine therapy: an exploratory clinical study

  2016cites this paper
• Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial

  2016cites this paper
• Eating Disorders and Obesity

  2016cites this paper
• Lisdexamfetamine Dimesylate Effects on Binge Eating Behaviour and Obsessive-Compulsive and Impulsive Features in Adults with Binge Eating Disorder.

  2016cites this paper
• A Novel Nociceptin Receptor Antagonist LY2940094 Inhibits Excessive Feeding Behavior in Rodents: A Possible Mechanism for the Treatment of Binge Eating Disorder

  2016cites this paper
• Binge-Eating Disorder in Adults

  2016cites this paper
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.

  2016cites this paper
• Binge-Eating-Störung

  2016cites this paper
• Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine

  2016cites this paper
• Pharmacological manipulation of impulsivity: A randomized controlled trial

  2016cites this paper
• Classification of Therapeutic and Experimental Drugs for Brown Adipose Tissue Activation: Potential Treatment Strategies for Diabetes and Obesity

  2016cites this paper
• The Relationship Between Binge Eating and Attention Deficit Hyperactivity Disorder

  2016cites this paper
• Effects of lisdexamfetamine in a rat model of binge-eating

  2015cites this paper
• Management and Outcomes of Binge-Eating Disorder

  2015influential citation
• Armodafinil in binge eating disorder: a randomized, placebo-controlled trial

  2015cites this paper
• Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.

  2015cites this paper
• Overview of the treatment of binge eating disorder

  2015cites this paper
• Pharmacotherapy of Binge-Eating Disorder: A Review

  2015cites this paper
• Pharmacological treatment of binge eating disorder: update review and synthesis

  2015influential citation
• Is there a clear winner in the pharmacological management of binge eating disorder?

  2015cites this paper
• Validation of the yale-brown obsessive compulsive scale modified for binge eating.

  2015cites this paper
• Add-on Atomoxetine Mitigated Different Symptom Domains in a Case of Early-Onset Schizophrenia

  2015cites this paper
• Comorbidity of bipolar disorder and eating disorders.

  2015cites this paper
• Comorbilidad entre el trastorno bipolar y los trastornos de la conducta alimentaria

  2015cites this paper
• Psychopharmacology in the Treatment of Eating Disorders

  2015cites this paper
• Comorbidity of bipolar disorder and eating disorders

  2015cites this paper
• Psychometric Properties of the Yale-Brown Obsessive Compulsive Scale Modified for Binge Eating in individuals with Binge Eating Disorder

  2015cites this paper
• Are Eating Disorders Related to Attention Deficit/Hyperactivity Disorder?

  2015cites this paper
• Introduction to Magellan’s Adopted Clinical Practice Guideline for the Assessment and Treatment of Patients With Eating Disorders Magellan Clinical Practice Guideline: Eating Disorders

  2015cites this paper
• Is there a clear winner in the pharmacological management of binge eating disorder?

  2015cites this paper
• Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials

  2015influential citation
• Atomoxetine Beyond ADHD: A Fact or Aritfact

  2015cites this paper
• Psychopharmacological management of binge eating disorder Psychopharmacological management of binge eating disorder

  2015influential citation
• Psychopharmacologic Treatment of Eating Disorders: Emerging Findings

  2015cites this paper
• Treatment of Binge Eating

  2014cites this paper
• Placebo response in binge eating disorder: a pooled analysis of 10 clinical trials from one research group.

  2014cites this paper
• Binge-Like Eating Attenuates Nisoxetine Feeding Suppression, Stress Activation, and Brain Norepinephrine Activity

  2014cites this paper
• Treatment of Binge Eating Disorder

  2014cites this paper
• Current and emerging drug treatments for binge eating disorder

  2014cites this paper
• Dietary-induced binge eating increases prefrontal cortex neural activation to restraint stress and increases binge food consumption following chronic guanfacine.

  2014cites this paper
• Pharmacological Approaches to the Management of Binge Eating Disorder

  2014cites this paper